Oncology: International Journal of Cancer Research and Treatment
Fecha de publicación: April 2018
DOI: https://doi.org/10.1159/000488314
Autores: Lyou Y. · Barber E. · Mehta R. · Lee T. · Goreal W. · Parajuli R.
Background: In the last couple of decades, breast conservation therapy, which utilizes a combination of surgery, radiotherapy, and endocrine or chemotherapy, has become the standard of care for treating early-stage breast cancer. This practice has been greatly beneficial in the improvement of the patient’s quality of life but has also led to the increased use of radiotherapy and associated soft-tissue sarcomas, with angiosarcoma being the most common malignancy.
Comentarios
Para dejar un comentario antes debes iniciar sesión:
¿No tienes una cuenta?
Regístrate a través de éste enlace.